Patrick Machado, 10% Owner at Urovant Sciences Ltd. (UROV), bought 7,500 shares at $8.35 ($63K) on 2019-06-10, disclosed to the SEC on 2019-06-11.
Open-market purchase of $63k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| UROV | BUY | 2019-06-19 | $56K | — | Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-19 | $55K | — | Filing → |